 |
Her2 (ECD and Neu )
HER2-positive breast cancer has gene mutation, more aggressive nature. |
| Her2 (ECD and Neu ) | ||||||
| Catalog Number | Product Description | Product Type | Size | |||
| 200-530-HER | Human Her2/neu/Erbb2/CD340 protein ELISA kit, 96 tests | ELISA Kit | 1 Kit | |||
| 200-600-HRH | Human Anti-Her2 Protein (ECD) IgG ELISA kit for Her2 vaccine, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| 200-600-HRH | Human Anti-Her2 Protein (ECD) IgG ELISA kit for Her2 vaccine, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| 200-610-HRM | Human Anti-Her2 Protein (ECD) IgM ELISA kit for Her2 vaccine, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| 200-620-HRH | Mouse Anti-Her2 Protein (ECD) ELISA kit for Her2 vaccine, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| 200-630-HRM | Mouse Anti-Her2 Protein (ECD) IgM ELISA kit for Her2 vaccine, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| 200-640-HRH | Human Anti-Her2 vaccine (E75-peptide) IgG ELISA kit, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| 200-650-HRM | Human Anti-Her2 vaccine (E75-peptide) IgM ELISA kit, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| 200-660-HRH | Mouse Anti-Her2 vaccine (E75-peptide) IgG ELISA kit, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| 200-670-HRM | Mouse Anti-Her2 vaccine (AE37-peptide) IgM ELISA kit, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| 200-700-HRH | Human Anti-Her2 vaccine (AE37-peptide) IgG ELISA kit, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| 200-710-HRM | Human Anti-Her2 vaccine (AE37-peptide) IgM ELISA kit, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| 200-720-HRH | Mouse Anti-Her2 vaccine (AE37-peptide) IgG ELISA kit, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| 200-730-HRM | Mouse Anti-Her2 vaccine (AE37-peptide) IgM ELISA kit, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| HER2-369-A | Anti-HER2 peptide IgG (cyclic 367-37; E75 vaccine candidate) Aff pure | Antibodies | 100 ul | |||
| HER2-597-A | Anti-HER2 peptide IgG (cyclic 597-626 vaccine candidate) Aff pure | Antibodies | 100 u | |||
| HER21-M | Mouse Monoclonal anti-human Her2/neu(erbB-2) protein IgG, aff pure | Antibodies | 100 ug | |||
| HER31-M | Rabbit mono anti-human Her2/Erbb2/Neu (1-652) protein IgG | Antibodies | ||||
| HER32-A | Anti-human Her2/Erbb2/Neu (1-652) protein IgG | Antibodies | 100 ul | |||
| HER33-M | Mouse mono anti-monkey/rhesus Her2/Erbb2/Neu (1-652) protein IgG | Antibodies | 100 ul | |||
| HER34-A | Anti-monkey/rhesus Her2/Erbb2/Neu (1-652) protein IgG | Antibodies | 100 ul | |||
| HER35-M | Humanized anti-human Her2/Erbb2/Neu protein IgG (Herceptin Biosimilar) | Antibodies | 100 ul | |||
| MA-20127 | Mouse Monoclonal Anti-Human Epidermal Growth Factor Receptor 2 (HER2) | |||||
| HER2-369-P | HER2 peptide, (369 377), E75 vaccine candidate | Peptide | 5 mg | |||
| HER2-563-P | HER2 peptide, cyclic, (563-598, cys-cys disulphide bond); vaccine candidate | Peptide | 5 mg | |||
| HER2-585-P | HER2 peptide, cyclic, (585-598, cys-cys disulphide bond); vaccine candidate | Peptide | 5 mg | |||
| HER2-597-P | HER2 peptide, cyclic, (597-626, cys-cys disulphide bond) vaccine candidate | Peptide | 5 mg | |||
| HER2-654-P | HER2 peptide, (654 662), GP2 vaccine candidate | Peptide | 5 mg | |||
| HER2-776-P | HER2 peptide, (776 790 fused with LRMK, C-Term ), GP2 vaccine candidate | Peptide | 5 mg | |||
| HER2-MP1 | HER2 multi peptide, (369-386, 688-703,971-984); vaccine candidate | Peptide | 5 mg | |||
| HER2-MP2 | HER2 multi peptide, (776-790,927-941,1116-1180); vaccine candidate | Peptide | 5 mg | |||
| HER2-MP3 | HER2 multi peptide, (42-56,98-114,328-345); vaccine candidate | Peptide | 5 mg | |||
| SP-51177-1 | HER2/neu (869-877) peptide [Leu-Leu-Asp-Ile-Asp-Glu-Thr-Glu-Tyr-OH; MW: 1110.19] | Pure Peptide | 1 mg | |||
| SP-52260-1 | HER2/neu(654-662) GP2 [H-Ile-Ile-Ser-Ala-Val-Val-Gly-Ile-Leu-OH; MW: 884.12] | Pure Peptide | 1 mg | |||
| HER24-R-10 | Recombinant (HEK) mouse Her2/Erbb2/Neu (23-653)-his tag fusion protein | Pure Protein | 10 ug | |||
| HER25-R-20 | Recombinant (E.Coli) Her2/neu(erbB-2) Herstatin protein, purified | Pure Protein | 20 ug | |||
| HER26-R-10 | Recombinant (HEK) mouse Her2/Erbb2/Neu (1-653)-hIgG1-Fc fusion protein | Pure Protein | 10 ug | |||
| HER265-R-10 | Recombinant (HEK) rat Her2/Erbb2/Neu (4-656)-his tag fusion protein | Pure Protein | 10 ug | |||
| HER29-R-10 | Recombinant (HEK) monkey/rhesus Her2/Erbb2/Neu (1-652)-his tag fusion protein | Pure Protein | 10 ug | |||
| HER30-R-10 | Recombinant (HEK) monkey/rhesus Her2/Erbb2/Neu (1-652)-hIgG1-Fc fusion protein | 10 ug | ||||
| HER21-R-10 | Recombinant (HEK) human Her2/Erbb2/Neu (1-652)-hIgG-Fc fusion protein | 10 ug | ||||
| HER22-R-5 | Recombinant (sf9) human Her2/Erbb2/Neu (676-1255)-GST fusion protein | Protein | 5 ug | |||
| HER23-R-10 | Recombinant (HEK) human Her2/Erbb2/Neu (1-652)-his tag fusion protein | Protein | 10 ug | |||
| HER266-R-10 | Recombinant (HEK) Human Her2/Erbb2/Neu (676?1255, intracellular domain) GST Tag | Protein | 10 ug | |||
| HER27-R-10 | HER2/ErB2 recombinant protein (1-652, extracellular domain), Human (E. coli) | Protein | 10 ug | |||
| HER28-R-10 | Recombinant (HEK) rat Her2/Erbb2/Neu (4-656)-hIgG1-Fc fusion protein | Protein | 10 ug | |||
| HER36-R-10 | Recombinant (HEK) human Her2/Erbb2/Neu (1-652)-Flag tag (DDDDK) fusion protein | Protein | 10 ug | |||
| HER36-R-50 | Recombinant (HEK) human Her2/Erbb2/Neu (1-652)-Flag tag (DDDDK) fusion protein | Protein | 50 ug | |||
| HER21-C | Recombinant human Her2/neu(erbB-2)-Fc protein control for WB | Western control | 100 ul | |||
| RDT-14000-HER | TruStrip RDT Her2 Protein Rapid test cards,25/pk | Rapid Test | 1pk | |||
| SM-101000-5 | EGFR/HER2 kinase inhibitor (>99%, M.wt 485.94) (Afatinib/BIBW-2992 | Chemical | 5 mg | |||
| SM-101000-50 | EGFR/HER2 kinase inhibitor (>99%, M.wt 485.94) (Afatinib/BIBW-2992 | Chemical | 50 mg | |||
| SM-101010-5 | Inhibitor of EGFR/HER family (Her1, Her2, Her3 or Pan Her-inhibitor) (BMS-59926/AC480, Mol wt 567.01, >99%) | Chemical | 5 mg | |||
| SM-101010-50 | Inhibitor of EGFR/HER family (Her1, Her2, Her3 or Pan Her-inhibitor) (BMS-59926/AC480, Mol wt 567.01, >99%) | Chemical | 50 mg | |||
| SM-101010-50 | Inhibitor of EGFR/HER family (Her1, Her2, Her3 or Pan Her-inhibitor) (BMS-59926/AC480, Mol wt 567.01, >99%) | Chemical | 50 mg | |||
| SM-101020-10 | Inhibitor of EGFR/HDAC/Her2 (CUDC-101; 7-((4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide, Mol wt 434.49, >99%) | Chemical | 10 mg | |||
| SM-101020-50 | Inhibitor of EGFR/HDAC/Her2 (CUDC-101; 7-((4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide, Mol wt 434.49, >99%) | Chemical | 50 mg | |||
| SM-101030-100 | Lapatinib, Inhibitor of Her2/EGFR (IC50=10 nM; mol wt 581; >98%) | Chemical | 100 mg | |||
| SM-101030-25 | Lapatinib, Inhibitor of Her2/EGFR (IC50=10 nM; mol wt 581; >98%) | Chemical | 25 mg | |||
| SM-101040-25 | Cell permeable Inhibitor of EGFR/ERB family/Her2 (Neratinib/HKI-272, mol wt 557.04; >98%) | Chemical | 25 mg | |||
| SM-101040-5 | Cell permeable Inhibitor of EGFR/ERB family/Her2 (Neratinib/HKI-272, mol wt 557.04; >98%) | Chemical | 5 mg | |||
| SM-101050-10 | Cell permeable Inhibitor of EGFR2/FGFR/PDGFr/JAK1/Her2 ((E)-4-((4-)1H-1,2,3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-trifluoromethyl)oxazole, mol wt 468; >98%) | Chemical | 10 mg | |||
| SM-101050-100 | Cell permeable Inhibitor of EGFR2/FGFR/PDGFr/JAK1/Her2 ((E)-4-((4-)1H-1,2,3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-trifluoromethyl)oxazole, mol wt 468; >98%) | Chemical | 100 mg | |||
| SM-101060-100 | Lapatinib Ditosylate (GW572016, GW2016, Tykerb, Tyverb), Autophos. Inhibitor of Her2/Erb2 (mol wt 925; >98%) | Chemical | 100 mg | |||
| SM-101060-25 | Lapatinib Ditosylate (GW572016, GW2016, Tykerb, Tyverb), Autophos. Inhibitor of Her2/Erb2 (mol wt 925; >98%) | Chemical | 25 mg | |||
| SM-101070-10 | Canertinib (CI-1033), kinase Inhibitor of Her2/Erb2/EGFR (mol wt 485; >98%) | Chemical | 10 mg | |||
| SM-101070-50 | Canertinib (CI-1033), kinase Inhibitor of Her2/Erb2/EGFR (mol wt 485; >98%) | Chemical | 50 mg | |||
| SM-101080-25 | CP-724,714, Potent and selective Inhibitor of Her2/Erb2 (mol wt 469; >98%) | Chemical | 25 mg | |||
| SM-101080-5 | CP-724,714, Potent and selective Inhibitor of Her2/Erb2 (mol wt 469; >98%) | Chemical | 5 mg | |||
| SM-101090-25 | AZD8931, reversible and competitive Inhibitor of Her2/Erbb2/ErbB3 (mol wt 473; >98%) | Chemical | 5 mg | |||
| SM-101090-5 | AZD8931, reversible and competitive Inhibitor of Her2/Erbb2/ErbB3 (mol wt 473; >98%) | Chemical | 5 mg | |||
| SM-101100-25 | AEE788 (NVP-AEE788), dual Inhibitor of Her2/Erbb2/EGFR (mol wt 440; >98%) | Chemical | 25 mg | |||
| SM-101100-5 | AEE788 (NVP-AEE788), dual Inhibitor of Her2/Erbb2/EGFR (mol wt 440; >98%) | Chemical | 5 mg | |||
| SM-101110-10 | Mubritinib (TAK-165), potent Inhibitor of Her2/Erbb2 (IC50=6 nm; mol wt 468; >98%) | Chemical | 10 mg | |||
| SM-101110-50 | Mubritinib (TAK-165), potent Inhibitor of Her2/Erbb2 (IC50=6 nm; mol wt 468; >98%) | Chemical | 50 mg | |||
| SM-101120-25 | Arry-380, Oral, potent Inhibitor of Her2/Erbb2 Tyr kinase (IC50=8 nM; mol wt 869; >98%) | Chemical | 25 mg | |||
| SM-101120-5 | Arry-380, Oral, potent Inhibitor of Her2/Erbb2 Tyr kinase (IC50=8 nM; mol wt 869; >98%) | Chemical | 5 mg | |||
| SM-101130-25 | Tak-285, dual Inhibitor of Her2/EGFR Tyr kinase (IC50=17 nM; mol wt 547; >98%) | Chemical | 25 mg | |||
| SM-101130-5 | Tak-285, dual Inhibitor of Her2/EGFR Tyr kinase (IC50=17 nM; mol wt 547; >98%) | Chemical | 5 mg | |||
| 200-510-RDT | TruStrip RDT Herceptin/Trastuzumab (anti-Her2) Rapid Test cards, 10/pk | Rapid Test | 1 pk | |||
| 200-530-RDT | TruStrip RDT Her2 Protein Rapid test cards, 10/pk | Rapid Test | 1 Pk | |||
| 200-600-01N | Human Anti-Her2 Protein (ECD domain) IgG negative control serum | Serum Controls | 1 ml | |||
| 200-600-02P | Human Anti-Her2 Protein (ECD domain) IgG positive control serum | Serum Controls | 1 ml | |||
| HER2-613-P | HER2 peptide, cyclic, (613-626, cys-cys disulphide bond); vaccine candidate | peptide | 5 mg | |||
| HER25-R-100 | Recombinant (E. Coli) Her2/neu(erbB-2) Herstatin protein, purified | Pure Protein | 100 ug | |||
| 200-530-HER | Human Her2/neu/Erbb2/CD340 protein ELISA kit, 96 tests, quantitative | ELISA Kit | 1 kit | |||
| 200-600-HRH | Human Anti-Her2 Protein (ECD) IgG ELISA kit for Her2 vaccine, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| 200-610-HRM | Human Anti-Her2 Protein (ECD) IgM ELISA kit for Her2 vaccine, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| 200-620-HRH | Mouse Anti-Her2 Protein (ECD) ELISA kit for Her2 vaccine, 96 tests, Quantitative | ELISA Ki | ||||
| 200-630-HRM | Mouse Anti-Her2 Protein (ECD) IgM ELISA kit for Her2 vaccine, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| 200-640-HRH | Human Anti-Her2 vaccine (E75-peptide) IgG ELISA kit, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| 200-650-HRM | Human Anti-Her2 vaccine (E75-peptide) IgM ELISA kit, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| 200-660-HRH | Mouse Anti-Her2 vaccine (E75-peptide) IgG ELISA kit, 96 tests, Quantitative | ELISA Kit | ||||
| 200-670-HRM | Mouse Anti-Her2 vaccine (AE37-peptide) IgM ELISA kit, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| 200-700-HRH | Human Anti-Her2 vaccine (AE37-peptide) IgG ELISA kit, 96 tests, Quantitative | ELISA Kit | ||||
| 200-710-HRM | Human Anti-Her2 vaccine (AE37-peptide) IgM ELISA kit, 96 tests, Quantitative | ELISA Kit | ||||
| 200-720-HRH | Mouse Anti-Her2 vaccine (AE37-peptide) IgG ELISA kit, 96 tests, Quantitative | ELISA Kit | ||||
| 200-730-HRM | Mouse Anti-Her2 vaccine (AE37-peptide) IgM ELISA kit, 96 tests, Quantitative | ELISA Kit | ||||
| AR-237-U | HER3 (A30), RNA Aptamer, unlabeled | RNA Aptamers | ||||
| HER2-369-A | Anti-HER2 peptide IgG (cyclic 367-37; E75 vaccine candidate) Aff pure | Antibodies | 100 ul | |||
| HER2-369-P | HER2 peptide, (369 ?377), E75 vaccine candidate | peptide | 5 mg | |||
| HER2-563-P | HER2 peptide, cyclic, (563-598, cys-cys disulphide bond); vaccine candidate | peptide | 5 mg | |||
| HER2-585-P | HER2 peptide, cyclic, (585-598, cys-cys disulphide bond); vaccine candidate | peptide | 5 mg | |||
| HER2-597-A | Anti-HER2 peptide IgG (cyclic 597-626 vaccine candidate) Aff pure | Antibodies | 100 u | |||
| HER2-597-P | HER2 peptide, cyclic, (597-626, cys-cys disulphide bond) vaccine candidate | peptide | 5 mg | |||
| HER2-776-P | HER2 peptide, (776 ? 790 fused with LRMK, C-Term ), GP2 vaccine candidate | peptide | 5 mg | |||
| HER2-MP1 | HER2 multi peptide, (369-386, 688-703,971-984); vaccine candidate | peptide | 5 mg | |||
| HER2-MP2 | HER2 multi peptide, (776-790,927-941,1116-1180); vaccine candidate | peptide | 5 mg | |||
| HER2-MP3 | HER2 multi peptide, (42-56,98-114,328-345); vaccine candidate | peptide | 5 mg | |||
| HER21-C | Recombinant human Her2/neu(erbB-2)-Fc protein control for WB | Western control | 100 ul | |||
| HER21-M | Mouse Monoclonal anti-human Her2/neu(erbB-2) protein IgG, aff pure | Antibodies | 100 ug | |||
| HER21-R-10 | Recombinant (HEK) human Her2/Erbb2/Neu (1-652)-hIgG-Fc fusion protein | Rec. Protein | 10 ug | |||
| HER22-R-5 | Recombinant (sf9) human Her2/Erbb2/Neu (676-1255)-GST fusion protein | Rec. Protein | 5 ug | |||
| HER23-R-10 | Recombinant (HEK) human Her2/Erbb2/Neu (23-652)-his tag fusion protein | Rec. Protein | 10 ug | |||
| HER24-R-10 | Recombinant (HEK) mouse Her2/Erbb2/Neu (23-653)-his tag fusion protein | Rec. Protein | 10 ug | |||
| HER25-R-20 | Recombinant (E.Coli) Her2/neu(erbB-2) Herstatin protein, purified | Rec. Protein | 20 ug | |||
| HER26-R-10 | Recombinant (HEK) mouse Her2/Erbb2/Neu (1-653)-hIgG1-Fc fusion protein | Rec. Protein | 10 ug | |||
| HER265-R-10 | Recombinant (HEK) rat Her2/Erbb2/Neu (4-656)-his tag fusion protein | Rec. Protein | 10 ug | |||
| HER266-R-10 | Recombinant (HEK) Human Her2/Erbb2/Neu (676?1255, intracellular domain) GST Tag | Rec. Protein | 10 ug | |||
| HER27-R-10 | Recombinant (HEK) rat Her2/Erbb2/Neu (4-656)-his tag fusion protein | Rec. Protein | 10 ug | |||
| HER28-R-10 | Recombinant (HEK) rat Her2/Erbb2/Neu (4-656)-hIgG1-Fc fusion protein | Rec. Protein | 10 ug | |||
| HER29-R-10 | Recombinant (HEK) monkey/rhesus Her2/Erbb2/Neu (1-652)-his tag fusion protein | Rec. Protein | 10 ug | |||
| HER30-R-10 | Recombinant (HEK) monkey/rhesus Her2/Erbb2/Neu (1-652)-hIgG1-Fc fusion protein | Rec. Protein | 10 ug | |||
| HER31-M | Rabbit mono anti-human Her2/Erbb2/Neu (1-652) protein IgG | Antibodies | 100 ul | |||
| HER32-A | Anti-human Her2/Erbb2/Neu (1-652) protein IgG | Antibodies | 100 ul | |||
| HER33-M | Mouse mono anti-monkey/rhesus Her2/Erbb2/Neu (1-652) protein IgG | Antibodies | 100 ul | |||
| HER34-A | Anti-monkey/rhesus Her2/Erbb2/Neu (1-652) protein IgG | Antibodies | 100 ul | |||
| HER35-M | Humanized anti-human Her2/Erbb2/Neu protein IgG (Herceptin Biosimilar) | Primary Antibodies | 100 ul | |||
| HER36-R-10 | Recombinant (HEK) human Her2/Erbb2/Neu (1-652)-Flag tag (DDDDK) fusion protein | Rec. Protein | 10 ug | |||
| HER36-R-50 | Recombinant (HEK) human Her2/Erbb2/Neu (1-652)-Flag tag (DDDDK) fusion protein | Rec. Protein | 50 ug | |||
| SM-101000-5 | EGFR/HER2 kinase inhibitor (>99%, M.wt 485.94) (Afatinib/BIBW-2992 | Chemical | 5 mg | |||
| SM-101000-50 | EGFR/HER2 kinase inhibitor (>99%, M.wt 485.94) (Afatinib/BIBW-2992 | Chemical | 50 mg | |||
| SM-101010-5 | Inhibitor of EGFR/HER family (Her1, Her2, Her3 or Pan Her-inhibitor) (BMS-59926/AC480, Mol wt 567.01, >99%) | Chemical | 5 mg | |||
| SM-101010-50 | Inhibitor of EGFR/HER family (Her1, Her2, Her3 or Pan Her-inhibitor) (BMS-59926/AC480, Mol wt 567.01, >99%) | Chemical | 50 mg | |||
| SM-101020-10 | Inhibitor of EGFR/HDAC/Her2 (CUDC-101; 7-((4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide, Mol wt 434.49, >99%) | Chemical | 10 mg | |||
| SM-101020-50 | Inhibitor of EGFR/HDAC/Her2 (CUDC-101; 7-((4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide, Mol wt 434.49, >99%) | Chemical | 50 mg | |||
| SM-101030-100 | Lapatinib, Inhibitor of Her2/EGFR (IC50=10 nM; mol wt 581; >98%) | Chemical | 100 mg | |||
| SM-101030-25 | Lapatinib, Inhibitor of Her2/EGFR (IC50=10 nM; mol wt 581; >98%) | Chemical | 25 mg | |||
| SM-101040-25 | Cell permeable Inhibitor of EGFR/ERB family/Her2 (Neratinib/HKI-272, mol wt 557.04; >98%) | Chemical | 25 mg | |||
| SM-101040-5 | Cell permeable Inhibitor of EGFR/ERB family/Her2 (Neratinib/HKI-272, mol wt 557.04; >98%) | Chemical | 5 mg | |||
| SM-101050-10 | Cell permeable Inhibitor of EGFR2/FGFR/PDGFr/JAK1/Her2 ((E)-4-((4-)1H-1,2,3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-trifluoromethyl)oxazole, mol wt 468; >98%) | Chemical | 10 mg | |||
| SM-101050-100 | Cell permeable Inhibitor of EGFR2/FGFR/PDGFr/JAK1/Her2 ((E)-4-((4-)1H-1,2,3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-trifluoromethyl)oxazole, mol wt 468; >98%) | Chemical | 100 mg | |||
| SM-101060-100 | Lapatinib Ditosylate (GW572016, GW2016, Tykerb, Tyverb), Autophos. Inhibitor of Her2/Erb2 (mol wt 925; >98%) | Chemical | 100 mg | |||
| SM-101060-25 | Lapatinib Ditosylate (GW572016, GW2016, Tykerb, Tyverb), Autophos. Inhibitor of Her2/Erb2 (mol wt 925; >98%) | Chemical | 25 mg | |||
| SM-101070-10 | Canertinib (CI-1033), kinase Inhibitor of Her2/Erb2/EGFR (mol wt 485; >98%) | Chemical | 10 mg | |||
| SM-101070-50 | Canertinib (CI-1033), kinase Inhibitor of Her2/Erb2/EGFR (mol wt 485; >98%) | Chemical | 50 mg | |||
| SM-101080-25 | CP-724,714, Potent and selective Inhibitor of Her2/Erb2 (mol wt 469; >98%) | Chemical | 25 mg | |||
| SM-101080-5 | CP-724,714, Potent and selective Inhibitor of Her2/Erb2 (mol wt 469; >98%) | Chemical | 5 mg | |||
| SM-101090-25 | AZD8931, reversible and competitive Inhibitor of Her2/Erbb2/ErbB3 (mol wt 473; >98%) | Chemical | 25 mg | |||
| SM-101090-5 | AZD8931, reversible and competitive Inhibitor of Her2/Erbb2/ErbB3 (mol wt 473; >98%) | Chemical | 5 mg | |||
| SM-101100-25 | AEE788 (NVP-AEE788), dual Inhibitor of Her2/Erbb2/EGFR (mol wt 440; >98%) | Chemical | 25 mg | |||
| SM-101100-5 | AEE788 (NVP-AEE788), dual Inhibitor of Her2/Erbb2/EGFR (mol wt 440; >98%) | Chemical | 5 mg | |||
| SM-101110-10 | Mubritinib (TAK-165), potent Inhibitor of Her2/Erbb2 (IC50=6 nm; mol wt 468; >98%) | Chemical | 10 mg | |||
| SM-101110-50 | Mubritinib (TAK-165), potent Inhibitor of Her2/Erbb2 (IC50=6 nm; mol wt 468; >98%) | Chemical | 50 mg | |||
| SM-101120-25 | Arry-380, Oral, potent Inhibitor of Her2/Erbb2 Tyr kinase (IC50=8 nM; mol wt 869; >98%) | Chemical | 25 mg | |||
| SM-101120-5 | Arry-380, Oral, potent Inhibitor of Her2/Erbb2 Tyr kinase (IC50=8 nM; mol wt 869; >98%) | Chemical | 5 mg | |||
| SM-101130-25 | Tak-285, dual Inhibitor of Her2/EGFR Tyr kinase (IC50=17 nM; mol wt 547; >98%) | Chemical | 25 mg | |||
| SM-101130-5 | Tak-285, dual Inhibitor of Her2/EGFR Tyr kinase (IC50=17 nM; mol wt 547; >98%) | Chemical | 5 mg | |||
| SP-51177-1 | HER2/neu (869-877) peptide [Leu-Leu-Asp-Ile-Asp-Glu-Thr-Glu-Tyr-OH; MW: 1110.19] | Pure Peptide | 1 mg | |||
| SP-52260-1 | HER2/neu(654-662) GP2 [H-Ile-Ile-Ser-Ala-Val-Val-Gly-Ile-Leu-OH; MW: 884.12] | Pure Peptide | 1 mg | |||
| 200-341-UL | Remicade (Infliximab/Infimab/Remsima/Inflectra) for ELISA | ELISA Kit | 100 ug | |||
| 200-340-CUX | Custom Testing of Samples for Remicade (Infliximab/Infimab/Remsima/Inflectra) by ELISA | Custom Service | 1 | |||
| 210-200-CUX | Custom Testing of Samples for Ipilimumab (Yervoy/MDX-010/MDX-101) by ELISA | Custom Service | 1 | |||
| 200-410-CUX | Custom Testing of Samples for Xolair/Omalizumab by ELISA | Custom Service | 1 | |||
| 200-410-XLG | Xolair/Omalizumab ELISA Kit for human, 96 tests, Quantitative | ELISA Kit | 1 Kit | |||
| 200-510-CUX | Custom Testing of Samples for Herceptin/Trastuzumab by ELISA | 1 | ||||
| 210-400-CUX | Custom Testing of Samples for Eculizumab (Soliris) by ELISA | Custom Service | 1 | |||
| 220-250-CUX | Custom Testing of Samples for Mertansine (Free or conjugated) Drug by ELISA | Custom Service | 1 | |||
| 210-100-CUX | Custom Testing of Samples for Erbitux (Cetuximab/C225/IMC225) by ELISA | Custom Service | 1 | |||
| 200-210-CUX | Custom Testing of samples for Rituximab/Rituxan ELISA Kit | Custom Service | 1 | |||
| 200-310-CUX | Custom Testing of Samples for Humira/Adalimumab by ELISA | Custom Service | 1 | |||
| 210-320-CUX | Custom Testing of Samples for Basiliximab (Simulect) by ELISA | Custom Service | 1 | |||
| 200-360-CUX | Custom Testing of Samples for Aflibercept/Eylea by ELISA | Custom Service | 1 | |||
| 200-800-CUX | Custom Testing of Samples for Avastin/Bevacizumab (Anti-VEGF) by ELISA | Custom Service | 1 | |||
| 200-880-CUX | Custom Testing of Samples for Lucentis/Ranibizumab by ELISA | Custom Service | 1 | |||
| 200-880-S1000 | Lucentis/Ranibizumab ELISA Standard (1000 ng/ml) for use ELISA | Standard | 1 ml | |||
| PLGF15-R-25 | Recombinant (E. coli) human placenta growth factor-1 (PLGF-1) Protein (>97%), biologically active | 25 ug | ||||
| PLGF15-R-5 | Recombinant (E. coli) human placenta growth factor-1 (PLGF-1) Protein (>97%), biologically active | 5 ug | ||||
| VEGF28-R-10 | Human Recombinant VEGF121 Protein (E. coli, his-tag) | Rec. Protein | 10 ug | |||
| AB-23085-A | Rabbit Anti-Human Tyrosine-protein kinase receptor UFO (Axl) (AXL- phosphor) IgG (aff pure) | Primary Antibodies | 100ug | |||
| AB-23085-CP | Human Tyrosine-protein kinase receptor UFO (Axl) control (non-phosphor) peptide | 100ug | ||||
| AB-23085-P | Human Tyrosine-protein kinase receptor UFO (Axl) control (AXL- phosphor) peptide | 100ug | ||||
| AR-302-U | Receptor Tyrosine Kinase (RET) Mutant (D4), RNA Aptamer, unlabeled | RNA Aptamers | Custom | |||
| RP-747 | Recombinant (E.Coli) Human Tyrosine Kinase ErbB-3 | Pure protein | 5 ug | |||
| RP-748 | Recombinant (E.Coli, his tag) Human Tyrosine Kinase ErbB-2 | Pure protein | 5 ug | |||
| SP-101378-1 | Tyrosine Kinase Peptide 3 [RRLIEDAE-pY-AARG], Acetylated, Amide, Phosphorylated (AA: Ac-Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-pTyr-Ala-Ala-Arg-Gly-NH2) (MW: 1640.75) | Pure Peptide | 1 mg | |||
| SP-101401-1 | Tyrosine Protein Kinase JAK 2 (AA: Val-Leu-Pro-Gln-Asp-Lys-Glu-pTyr-pTyr-Lys-Val-Lys-Glu-Pro-Gly-Glu) (MW: 2082.18) | Pure Peptide | 1 mg | |||
| SP-101516-5 | pp60(v-SRC) Autophosphorylation Site, Protein Tyrosine Kinase Substrate (AA: Arg-Arg-Leu-Ile-Glu-Asp-Asn-Glu-Tyr-Thr-Ala-Arg-Gly) (MW: 1592.74) | Pure Peptide | 5 mg | |||
| SP-101518-5 | Biotin-RR-SRC, Insulin Receptor Tyrosine Kinase Substrate (AA: Biotin -Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr-Ala-Ala-Arg-Gly) (MW: 1745.99) | Pure Peptide | 5 mg | |||
| SP-86883-1 | Biotin-Tyrosine Kinase Peptide 1, amide (AA: Biotin-Lys-Val-Glu-Lys-Ile-Gly-Glu-Gly-Thr-Tyr-Gly-Val-Val-Tyr-Lys-NH2) (MW: 1895.27) | Pure Peptide | 1 mg | |||
| MCD200R-B | Anti-Mouse CD200R, Biotin (Clone OX110) (rat IgG2a) | Antibodies | 100 tests | |||
| MCD200R-F | Anti-Mouse CD200R, FITC (Clone OX110) (rat IgG2a) | Antibodies | 50 Tests | |||
| MCD200R-M | Anti-Mouse CD200R, Purified (Clone OX110) (rat IgG2a) | Primary Antibodies | 100 ug | |||
| MCD200R-PE | Anti-Mouse CD200R, PE (Clone OX110) (rat IgG2a) | Antibodies | 50 tests | |||
| ERB21-A | Anti-Rat Estrogen Receptor-beta 2 (ER-b) IgG #1, aff pure | Primary Antibodies | 100 ug | |||
| ERB21-P | Rat Estrogen Receptor-beta 2 (ER-b) Control/blocking peptide #1 | Peptide | 100 ug | |||
| ERB21-S | Anti-Rat Estrogen Receptor-beta 2 (ER-b) antiserum #1 | Primary Antibodies | 100 ul | |||
| ERB22-M | Mouse Monoclonal Anti-Human Estrogen Receptor-beta (ER-beat) protein IgG | Primary Antibodies | 100 ul | |||
| CTLA45-R-25 | Recombinant (HEK) Human CTLA-4 (Cytotoxic T-Lymphocyte Antigen 4/CD152) protein (37-162aa, >95%, his-tag, low endotoxin) | 25 ug | ||||
| CTLA46-R-25 | Recombinant (HEK) Mouse CTLA-4 (Cytotoxic T-Lymphocyte Antigen 4/CD152) protein (36-162aa, >95%, his-tag, low endotoxin) | 25 ug | ||||
| 100-205-TNR | Rat TNF-alpha ELISA Kit, High Sensitivity, 96 tests, Quantitative | 1 kit | ||||
